TACT: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) No edit summary |
Rim Halaby (talk | contribs) |
||
Line 37: | Line 37: | ||
| Style="width:30%"|'''Study Type'''|| Style="width:70%"|Interventional | | Style="width:30%"|'''Study Type'''|| Style="width:70%"|Interventional | ||
|- | |- | ||
| '''Study Phase''' || | | '''Study Phase''' ||Phase 3 | ||
|- | |- | ||
| Colspan="2" style="background:Gainsboro" align="center"|'''Study Design''' | | Colspan="2" style="background:Gainsboro" align="center"|'''Study Design''' | ||
Line 53: | Line 53: | ||
| '''Primary Purpose'''||Treatment | | '''Primary Purpose'''||Treatment | ||
|- | |- | ||
| '''Condition'''|| | | '''Condition'''||Coronary artery disease | ||
|- | |- | ||
| '''Intervention'''|| | | '''Intervention'''||EDTA <vs> EDTA placebo <br> High dose vitamin <br> High dose vitamin placebo | ||
|- | |- | ||
| '''Study Arms'''|| | | '''Study Arms'''||Active Comparator: EDTA + high dose vitamin <br>Placebo Comparator: EDTA + high dose vitamin placebo <br>Placebo Comparator: EDTA placebo + high dose vitamin <br>Placebo Comparator: EDTA placebo + high dose vitamin placebo | ||
|- | |- | ||
| '''Population Size'''|| | | '''Population Size'''||1708 | ||
|- | |- | ||
|} | |} |
Revision as of 18:08, 19 November 2013
High Density Lipoprotein Microchapters |
Diagnosis |
---|
Treatment |
Clinical Trials |
Case Studies |
TACT On the Web |
American Roentgen Ray Society Images of TACT |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Official Title
Trial to Assess Chelation Therapy (TACT)
Objective
The purpose of this study is to determine the safety and effectiveness of ethylene diamine tetra-acetic (EDTA) chelation therapy in individuals with coronary artery disease.
Sponsor
Mt. Sinai Medical Center, Miami
Timeline
Timeline | |
Start Date | September 2003 |
Run-In Period | August 2012 |
End Date | October 2011 |
Status | Completed |
The previous information was derived from ClinicalTrials.gov on 09/20/2013 using the identification number NCT------.
Study Description
Study Description | |
Study Type | Interventional |
Study Phase | Phase 3 |
Study Design | |
Allocation | Randomized |
Endpoint | Efficacy Study |
Interventional Model | Factorial Assignment |
Masking | Double Blind (Subject, Investigator) |
Study Details | |
Primary Purpose | Treatment |
Condition | Coronary artery disease |
Intervention | EDTA <vs> EDTA placebo High dose vitamin High dose vitamin placebo |
Study Arms | Active Comparator: EDTA + high dose vitamin Placebo Comparator: EDTA + high dose vitamin placebo Placebo Comparator: EDTA placebo + high dose vitamin Placebo Comparator: EDTA placebo + high dose vitamin placebo |
Population Size | 1708 |
The previous information was derived from ClinicalTrials.gov on 09/20/2013 using the identification number NCT-----.